Longevity & Aging · Diets · Metabolic & Cardiometabolic
caloric restriction improves cardiometabolic risk factors
In plain terms: Does eating fewer calories improve heart and blood-sugar health?
Strong support Longevity & Aging
Part of: • Insulin & Metabolic Aging
RefutedContestedStrong support
consensus score 0.88
Yes, though it improves risk markers (not proven lifespan) and benefits fade if weight returns.
📅 Last reviewed: 2026-07-15 ⓘ
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: All trials, pooled (Meta-analysis)
MechanismIn-vitroAnimalObservationalRCTMeta-analysis
How the studies fall
16 support 0 contradict 0 tested null 2 mixed · 18 sources, 15 independent groups
What the evidence shows
Two years of caloric restriction improved cardiometabolic risk factors and slowed an epigenetic pace-of-aging measure in healthy non-obese humans (CALERIE) - the strongest human design here, but surrogate endpoints only; it does NOT prove CR extends human lifespan, and benefits reverse with weight regain.
The evidence (23)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Nasrollahzadeh J, Khandouzi N, Maroofi M 2023 · Int J Endocrinol Metab | RCT | supports | moderate | Reduced-calorie diet lowered inflammatory and metabolic factors in overweight/obese with cardiovascular risk factors. |
| Warmbrunn MV, Biswas RK, Don AS, Lastra Cagigas M, Li Y, Yang L, Twigg SM, Fiorito G, Fontana L 2026 · Nature Communications | RCT | supports | high | CALERIE-2 mechanistic sub-study (24-month RCT, non-obese adults); CR increased HMW adiponectin and reduced ceramides (C16:0, C18:0, C24:0) linked to insulin resistance, partially mediating improved insulin sensitivity/secretion; effects att |
| Werndle VV, Stefanovic J, Reljic D 2026 · Nutrients | meta-analysis | supports | moderate | Systematic review/meta-analysis, 46 studies, 12,128 participants; diet-only intervention reduced MetS z-score by -0.72 units (17 arms, p<0.001) and consistently improved fasting glucose, triglycerides, HDL, waist circumference, and blood pr |
| Ryan CP, Corcoran DL, Banskota N, Eckstein Indik C, Floratos A, Friedman R, Kobor MS, Kraus VB, Kraus WE, MacIsaac JL, Orenduff MC, Pieper CF, White JP, Ferrucci L, Horvath S, Huffman KM, Belsky DW 2025 · Nat Aging | RCT | supports | moderate | CALERIE multi-omics: CR slowed DunedinPACE epigenetic aging |
| Maroofi M, Nasrollahzadeh J 2020 · Lipids Health Dis | RCT | supports | moderate | Intermittent vs continuous CR both improved body weight and cardiometabolic markers in overweight hypertriglyceridemic subjects. |
| Warmbrunn MV, Yang L, Kishore Biswas R, Ryan CP, Harper A, Belsky DW, Fiorito G, Fontana L 2026 · Diabetes care | RCT | mixed | high | CALERIE-2 post-hoc (n=190): sustained CR-induced weight loss maintained improvements in insulin AUC and IGF-1/IGFBP-1 ratio and lower biological age; weight regain (>5%) reversed these insulin-IGF-1 pathway benefits. |
| Houston DK, Fanning J, Nicklas BJ, Delany JP, Hsu FC, Chen SH, Walkup M, Neiberg RH, Stowe CL, Kennedy K, Espeland MA, Ard JD, Miller ME, Rejeski WJ, Kritchevsky SB 2026 · The journals of gerontology. Series A, Biological sciences and medical sciences | RCT | supports | low | HALLO-P: 90 older adults (60+) randomized to 20% CR in-person, remote CR, or TRE for 9 months; CR/RCR lost 4.4-6.7kg fat+lean mass, and glucose and cholesterol improved in all 3 groups despite CR target not fully achieved (actual CR only 4. |
| Wei Z, Yang B, Wang H, Lv S, Chen H, Liu D 2024 · Chinese medical journal | observational | supports | low | Narrative review of CR-Sirtuin-cardiovascular mechanistic literature; asserts CR benefits CVS via sirtuin pathways but presents no new primary human outcome data, mechanism/animal evidence only cited. |
| Schroor MM, Joris PJ, Plat J, Mensink RP 2024 · Adv Nutr | meta-analysis | mixed | moderate | SR+MA of 28 RCTs (2,043 participants, 2-52 wk, healthy/overweight adults, diabetes excluded) comparing intermittent energy restriction (TRE k=7, ADF k=10, 5:2 k=11) with continuous energy restriction (CER). Every arm was calorie-restricted and only IER-minus-CER differences were pooled: lipids, glucose, insulin, HOMA-IR, BP did not differ ('the 3 IER diets combined did not lead to superior improvements in anthropometrics and cardiometabolic risk markers compared with CER diets'). No CR-vs-no-restriction contrast, so it cannot test whether caloric restriction improves cardiometabolic risk factors. |
| Trouwborst I, Goossens GH, Astrup A, Saris WHM, Blaak EE 2021 · Nutrients | observational | supports | moderate | 8-wk LCD improved cardiometabolic risk factors with weight loss; partly maintained at 6mo |
| Semnani-Azad Z, Khan TA, Chiavaroli L, Chen V, Bhatt HA, Chen A, Chiang N, Oguntala J, Kabisch S, Lau DC, Wharton S, Sharma AM, Harris L, Leiter LA, Hill JO, Hu FB, Lean ME, Kahleová H, Rahelic D, Salas-Salvadó J, Kendall CW, Sievenpiper JL 2025 · BMJ | meta-analysis | supports | moderate | Network MA of RCTs: continuous energy restriction improved intermediate cardiometabolic outcomes vs ad-lib ⚠️ correction-on-file (Crossref) - kept, corrigendum not retraction |
| Most J, Gilmore LA, Smith SR, Han H, Ravussin E, Redman LM 2018 · Am J Physiol Endocrinol Metab | RCT | supports | high | 25% CR over 24mo improved cardiometabolic risk (BP, lipids, insulin) in healthy nonobese adults |
| Li Y, Xu X, Zheng Y, He X, Wang J, Liu Z, Jiang Y, Suo C, Zhang T, Gao X, Chen X, Xu K 2026 · BMC medicine | RCT | supports | moderate | CardioMetAge aging-clock study (NHANES/UK Biobank derivation + validation); two-year caloric restriction intervention (CALERIE) slowed CardioMetAge progression by 1.23 years (95% CI 0.61-1.84) relative to ad libitum control. |
| Peters B, Schwarz J, Schuppelius B, Ottawa A, Koppold DA, Weber D, Steckhan N, Mai K, Grune T, Pfeiffer AFH, Michalsen A, Kramer A, Pivovarova-Ramich O 2025 · Sci Transl Med | RCT | contradicts | high | Intended-isocaloric 8-h TRE crossover (n=31): 'During the restricted 8-hour eating period, participants were asked to consume their habitual food quality and quantity.' Only a 'minor daily calorie deficit (eTRE, -167 kilocalories/day)' arose; caloric restriction was not an arm or contrast. |
| Duszka K, Gregor A, Guillou H, König J, Wahli W 2020 · Cells | observational | mixed | low | Narrative review on CR-PPAR shared pathways affecting metabolism/health/longevity; summarizes mechanistic literature only, no primary cardiometabolic outcome data presented. |
| Sedej S, Stockner A, Schreiber R, Diwan A, Breinbauer R, Abdellatif M 2025 · Cardiovascular diabetology | animal | supports | moderate | Mouse model of obesity-related HFpEF; genetic/pharmacologic ATGL inhibition (atglistatin) in adipose tissue improved diastolic dysfunction and lowered adipose IL-1β more effectively than caloric restriction, which showed only partial benefi |
| Åberg S et al 2026 · Clinical nutrition (Edinburgh, Scotland) | RCT | supports | moderate | 12-week RCT, 229 completers with overweight/obesity on hypocaloric diets (wholegrain rye vs refined wheat); both groups lost similar weight, but the rye group had a 17% CRP reduction; baseline HOMA-IR/CRP correlated with fat-mass change. |
| Dhana K, Aggarwal NT, Voigt RM, Ventrelle J, Rajan KB, Kaddurah-Daouk R, Marcovina SM, Liu X, Agarwal P, Tangney C, Arfanakis K, Sacks FM, Barnes LL 2025 · International journal of obesity (2005) | observational | supports | moderate | MIND trial (n=518 overweight/obese adults 65-84), 3-year mild CR (250kcal) diet; >10% weight loss vs no loss produced LDL -8.3%, triglycerides -28.2%, HDL +12.4%, hs-CRP -59.4%, adiponectin +53.7%, independent of which diet arm. |
| Ikizler TA, Robinson-Cohen C, Ellis C, Headley SAE, Tuttle K, Wood RJ, Evans EE, Milch CM, Moody KA, Germain M, Limkunakul C, Bian A, Stewart TG, Himmelfarb J 2018 · J Am Soc Nephrol | RCT | supports | moderate | Caloric restriction (+/-exercise) in moderate-severe CKD improved proinflammatory metabolic milieu and fat mass. |
| Kraus WE, Bhapkar M, Huffman KM, Pieper CF, Krupa Das S, Redman LM, Villareal DT, Rochon J, Roberts SB, Ravussin E, Holloszy JO, Fontana L, CALERIE Investigators 2019 · Lancet Diabetes Endocrinol | RCT | supports | moderate | CALERIE-2 RCT n=218: ~12% CR x2y improved LDL, BP, CRP, insulin sensitivity, MetS score |
| Leal DP, Gonçalinho GHF, Tavoni TM, Kuwabara KL, Paccanaro AP, Freitas FR, Strunz CMC, César LAM, Maranhão RC, Mansur AP 2022 · Antioxidants | RCT | mixed | low | Energy restriction vs atorvastatin in women with premature CAD: CR affected LDL and HDL function but less than statin. |
| Stekovic S, Hofer SJ, Tripolt N, Aon MA, Royer P, Pein L, Stadler JT, Pendl T, Prietl B, Url J, Schroeder S, Tadic J, Eisenberg T, Magnes C, Stumpe M, Zuegner E, Bordag N, Riedl R, Schmidt A, Kolesnik E, Verheyen N, Springer A, Madl T, Sinner F, de Cabo R, Kroemer G, Obermayer-Pietsch B, Dengjel J, Sourij H, Pieber TR, Madeo F 2019 · Cell Metab | RCT | supports | moderate | Alternate-day fasting (~37% calorie cut) improved cardiovascular markers, reduced LDL, sICAM-1, trunk fat in healthy adults. |
| Laysandro R, Harijanto EA, Sie NA 2026 · Frontiers in cardiovascular medicine | n-of-1 | supports | low | Case report: one 43-year-old man with severe CAD/obesity underwent 10-month supervised large caloric deficit + high protein diet + exercise; lost 50kg, HDL rose, HbA1c fell, BP improved, but LDL/total cholesterol rose. |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.